Funding Announcements

"Our value proposition is simple. We help companies address the immense challenge of analyzing unstructured language data, which is growing at a rapid pace,"

"Following the recent announcement of Dr. Jane Osbourn, OBE, as Chair of Mogrify, I am delighted we have been able to make an initial close of this fundraising round, with the backing of both existing and new investors. Due to the significant interest, we have been able to secure this growth-funding without engaging in a protracted and distracting fund-raising process. Having now raised over $20 million, we can focus on delivery of our business strategy with the support of an aligned investor group. We will continue to engage with high-caliber investors with computational biology and cell therapy domain expertise as part of our on-going investor relations and capital markets strategy."

"Our goal is to bring much-needed improvement to the lives of three million dialysis patients. This investment allows us to take a big step towards this, and we are delighted to have won the backing of a consortium of smart, well-funded investors."

"The indexing industry is in urgent need of transformation since the dominant index providers currently offer investors limited choice and are inflexible. Moorgate Benchmarks is solving this problem by offering index providers and product issuers the services they need to innovate and deliver true choice to all investors. We are delighted to have secured a significant investment from ETFS Capital which will accelerate the build-out of our full-services, flexible offering."

"Our ethos and drive is to change the world, especially in the field of healthcare."